NCT03202433

Brief Summary

Reduce stress associated with needle aspiration, in voluntary and replacement blood donors. This study has not been completed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 28, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2017

Completed
Last Updated

November 28, 2017

Status Verified

November 1, 2017

Enrollment Period

11 months

First QC Date

June 18, 2017

Last Update Submit

November 24, 2017

Conditions

Keywords

Virtual RealityStress ReductionNeedle AspirationBlood DonorsIntervention

Outcome Measures

Primary Outcomes (1)

  • Numerical scale of pain (EN)

    Main measure for pain perception

    Once finalized the donation that should last a maximum of 15 minutes.

Secondary Outcomes (2)

  • Heart rate. Measurement with automatic equipment

    Before donating, after the puncture and after the extraction of the needle.Maximum duration of the procedure, 15 minutes

  • Blood pressure. Measurement with automatic equipment

    Before donating, after the puncture and after the extraction of the needle.Maximum duration of the procedure, 15 minutes

Study Arms (2)

Virtual Reality Distractor

EXPERIMENTAL

The objective is to apply a technique, using virtual reality lenses, with relaxing audio-visual contents of no more than ten minutes, to reduce stress before and during the blood donation process and to respond to the level of pain perceived during donation, either post-puncture and withdrawal of the needle

Device: Use of virtual reality lenses, with relaxing audio-visual contents

Traditional Blood Donation Process

NO INTERVENTION

The objective is to respond to the level of pain perceived during donation, either post-puncture and withdrawal of the needle, without virtual reality support

Interventions

Use of virtual reality lenses (and audio) as a distraction for the blood donor patients.

Virtual Reality Distractor

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and / or visualize the numerical scale of pain
  • Spanish spoken
  • Greater than 50 Kilograms of weight
  • Blood hemoglobin: Greater than 12.5 g% in women and greater than 13.5 g% in men
  • Have been accepted as a blood donor.

You may not qualify if:

  • Unable to understand and / or visualize the numerical scale of pain
  • Does not speak Spanish
  • Less than 50 Kilograms
  • Blood hemoglobin: Less than 12.5 g% in women and less than 13.5 g% in men.
  • Have been rejected as a blood donor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blood and Tissue Center

Valparaíso, 2340000, Chile

RECRUITING

Related Publications (2)

  • Riva G, Raspelli S, Pallavicini F, Grassi A, Algeri D, Wiederhold BK, Gaggioli A. Interreality in the management of psychological stress: a clinical scenario. Stud Health Technol Inform. 2010;154:20-5.

    PMID: 20543263BACKGROUND
  • Mahrer NE, Gold JI. The use of virtual reality for pain control: a review. Curr Pain Headache Rep. 2009 Apr;13(2):100-9. doi: 10.1007/s11916-009-0019-8.

    PMID: 19272275BACKGROUND

Study Officials

  • Pedro Meneses

    Medical College of Chile

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blocks swapped.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Allocation of two groups (Study and Control)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Technologist

Study Record Dates

First Submitted

June 18, 2017

First Posted

June 28, 2017

Study Start

December 30, 2016

Primary Completion

November 24, 2017

Study Completion

November 24, 2017

Last Updated

November 28, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Clinical Study Report Access
Study Protocol (ISSN 0124-8146)Access
Clinical Practice Guide Access

Locations